Recombinant MS4A1, CD20 (Ublituximab Biosimilar) antibody
This Human Chimeric antibody specifically detects MS4A1, CD20 (Ublituximab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538060
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant MS4A1, CD20 (Ublituximab Biosimilar) antibody (ABIN7538060)
Target
MS4A1, CD20 (Ublituximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human, Mouse
Clonality
Chimeric
Conjugate
This MS4A1, CD20 (Ublituximab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Ublituximab Biosimilar - Anti-MS4A1, CD20 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- MS4A1, CD20 (Ublituximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Ublituximab is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects.
-
CAS-No
- 1174014-05-1
Target
-
You are here:
